检索结果-南通市图书馆

Preoperative serum carbohydrate antigen 19-9 levels predict early recurrence after the resection of early-stage pancreatic ductal adenocarcinoma

引用

World Journal of Gastrointestinal Surgery 2021年第11期13卷 1423-1435页

作者： Sarang Hong Ki Byung Song Dae Wook Hwang Jae Hoon Lee Woohyung Lee Eunsung Jun Jaewoo Kwon Yejong Park Seo Young Park naru kim Dakyum Shin Hyeyeon kim Minkyu Sung Yunbeom Ryu Song Cheol kim Division of Hepatobiliary and Pancreatic Surgery Department of SurgeryAsan Medical CenterSeoul 05505South Korea Department of Surgery Kangbuk Samsung HospitalSungkyunkwan University School of MedicineSeoul 03181South Korea Department of Statistics and Data Science Korea National Open UniversitySeoul 03087South Korea Department of Surgery Uijeongbu St.Mary's HospitalCollege of MedicineGyeonggido 11765South Korea

BACKGROUND Pancreatic ductal adenocarcinoma(PDAC)is a serious disease with a poor *** a minority of patients undergo surgery due to the advanced stage of the disease,and patients with early-stage disease,who are expected to have a better prognosis,often experience ***,it is important to identify the risk factors for early recurrence and to develop an adequate treatment *** To evaluate the predictive factors associated with the early recurrence of earlystage *** This study enrolled 407 patients with stage I PDAC undergoing upfront surgical resection between January 2000 and April *** recurrence was defined as a diagnosis of recurrence within 6 mo of *** optimal cutoff values were determined by receiver operating characteristic(ROC)*** and multivariate analyses were performed to identify the risk factors for early *** Of the 407 patients,98 patients(24.1%)experienced early disease recurrence:26(26.5%)local and 72(73.5%)distant *** total,253(62.2%)patients received adjuvant *** ROC curve analysis,the optimal cutoff values for early recurrence were 70 U/mL and 2.85 cm for carbohydrate antigen 19-9(CA 19-9)levels and tumor size,*** the 181 patients with CA 19-9 level>70 U/mL,59(32.6%)had early recurrence,compared to 39(17.4%)of 226 patients with CA 19-9 level≤70 U/mL(P70 U/mL(P=0.006),tumor size>2.85 cm(P=0.004),poor differentiation(P=0.008),and non-adjuvant chemotherapy(P=0.025)were significant risk factors for early recurrence in early-stage *** Elevated CA 19-9 level(cutoff value>70 U/mL)can be a reliable predictive factor for early recurrence in early-stage *** adjuvant chemotherapy can prevent early recurrence,it should be recommended for patients susceptible to early recurrence.

关键词： Pancreatic ductal adenocarcinoma Early recurrence Upfront surgery Carbohydrate antigen 19-9 Adjuvant chemotherapy

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：